Skip to main content
Sunday, July 26, 2026
BTC $64,428 ▲ 0.18%
GOKHSHTEIN.
Live WirePoliticsMarketsDigital AssetsTechnologySports
DeFi & On-ChainU.S. EquitiesMacro & RatesResearch
SubscribeGMarkets
Live WirePoliticsMarketsDigital AssetsTechnologySportsDeFi & On-ChainU.S. EquitiesMacro & RatesResearchGMarkets ↗
SubscribeGMarkets →
LIVE
ADA$0.165up+0.28%ETH$1,877up+0.22%LINK$8.39up+0.23%SOL$74.66up+0.26%BTC$64,428up+0.18%XRP$1.10up+0.20%S&P 5007,412up+0.05%Nasdaq24,976down−0.64%Dow51,947up+0.46%RUT2,930down−0.35%TNX4.68%down−0.51%TYX5.16%down−0.17%FVX4.43%down−0.78%IRX3.81%up+0.13%VIX18.58down−0.64%GOLD$4,070.80up+0.51%SILVER$58.91up+1.47%OIL$89.31down−3.12%DXY101.47down−0.00%NVDA$206.84down−0.92%AAPL$333.02up+3.53%TSLA$313.03down−2.08%META$595.19down−1.80%MSFT$381.70up+0.03%AMZN$232.11down−0.66%GOOGL$319.74up+0.65%Fear & Greed26 — FearADA$0.165up+0.28%ETH$1,877up+0.22%LINK$8.39up+0.23%SOL$74.66up+0.26%BTC$64,428up+0.18%XRP$1.10up+0.20%S&P 5007,412up+0.05%Nasdaq24,976down−0.64%Dow51,947up+0.46%RUT2,930down−0.35%TNX4.68%down−0.51%TYX5.16%down−0.17%FVX4.43%down−0.78%IRX3.81%up+0.13%VIX18.58down−0.64%GOLD$4,070.80up+0.51%SILVER$58.91up+1.47%OIL$89.31down−3.12%DXY101.47down−0.00%NVDA$206.84down−0.92%AAPL$333.02up+3.53%TSLA$313.03down−2.08%META$595.19down−1.80%MSFT$381.70up+0.03%AMZN$232.11down−0.66%GOOGL$319.74up+0.65%Fear & Greed26 — Fear
GOKHSHTEIN.
Media · Est. 2019
The front page of everything. Breaking news and sharp analysis across politics, markets, crypto, technology, and sports — with live market data built in.
Markets
Market OverviewDigital AssetsU.S. EquitiesMacro & RatesResearch
Editorial
Politics & PolicyTechnologySports BusinessResearch
Terminal
GMarkets ↗Go PRO
Company
AboutAdvertiseSubscribe
Legal
Privacy PolicyTerms of ServiceDisclosures
© 2026 Gokhshtein Media. All rights reserved.
PrivacyTermsDisclosures
Tag

drug costs

1 article

TrumpRx Adds Hundreds of Generics, Escalating Drug Cost Battle
Politics & Policy68d ago
TrumpRx Adds Hundreds of Generics, Escalating Drug Cost Battle
The platform's expansion to 300 new generic drugs directly challenges Big Pharma and pharmacy benefit managers, aiming to cut consumer costs